BELLUS Health provides update on activities

About this update from Bluenergies Ltd.

[{"type":"text","content":"\n\n\n\nLAVAL, QC, Oct. 21 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS;\nTSX: BLU) is pleased to provide an update on its branded nutraceutical and\npharmaceutical activities. The commercial activities surrounding sales of its\nfirst natural health product, VIVIMIND(TM), to protect memory function are in\nfull gear. Through BELLUS Health's wholly owned subsidiary, OVOS Natural\nHealth Inc., VIVIMIND(TM) became available at the beginning of September on\nthe Internet and progressively at over 2,000 retail points of sale across\nCanada. The distribution of the brand is on target as OVOS Natural Health has\nreceived many orders from major national drug, grocery, and mass merchandisers\nand Quebec natural health food stores, which will further translate into\nVIVIMIND(TM) becoming increasingly available to consumers by year-end. The\nCompany is committed to the success of VIVIMIND(TM) and has therefore launched\nextensive marketing, sales and public relations campaigns to increase\nawareness and media exposure of the brand across Canada.\n\n\nTargeted at healthy baby boomers, VIVIMIND(TM) is a patent-protected,\nclinically tested, scientifically proven brand that is being offered to\nconsumers to protect their aging memory. VIVIMIND(TM)'s uniqueness and\nefficacy are anticipated to not only take market share in the current\ncognition brand segment, but also grow the size of the market. VIVIMIND(TM) is\nexpected to create and address a largely underserved self-care market. As part\nof its commercial activities to grow and expand into the global market, OVOS\nNatural Health is actively taking steps to launch in other geographies as\nearly as 2009 and 2010, via large retail organizations and via potential\npartners with proven track records in the natural health, consumer health,\nmulti-level marketing and naturopathic doctor channels. Eight months into the\ncreation of OVOS Natural Health, the masthead brand VIVIMIND(TM) has reached\nall milestones in its commercial launch development and is on track to deliver\nits 2008 sales projections.\n\n\nThe pharmaceutical programs are also progressing; BELLUS Health is\nadvancing its programs in Type II diabetes and certain features of metabolic\nsyndrome and Alzheimer's disease. The Company expects to file the\nInvestigational New Drug application for the second Phase III clinical trial\n...

More updates from Bluenergies Ltd.